
€69,00
| Dosage | 10mg |
|---|
VISA, APPLEPAY, GPAY
Hassle-free returns within 30 days
Guaranteed quality
We’re here anytime
From €130
CJC + IPA is a research combination of two well studied peptides, CJC-1295 and Ipamorelin, that are widely investigated for their role in stimulating natural growth hormone release pathways. This pairing is commonly explored in studies focused on recovery, body composition, metabolic regulation, and endocrine signalling.
CJC-1295 functions as a long acting growth hormone releasing hormone analogue, extending the duration of pituitary stimulation, while Ipamorelin acts as a selective growth hormone secretagogue that promotes pulsatile GH release without significantly affecting cortisol or prolactin levels.
Together, this combination is studied for its synergistic effect on growth hormone activity, making it a widely researched tool in metabolic science, tissue repair studies, and performance related research.
Precision and consistency are essential when working with growth hormone related compounds. Novapepts supplies research grade CJC + IPA manufactured under strict quality controlled conditions to ensure reliable and reproducible laboratory results.
Researchers choose Novapepts because our compounds are:
• Produced under strict quality controlled manufacturing standards
• Independently tested for purity and composition
• Securely packaged and shipped worldwide with tracking
• Supported by responsive customer service and flexible payment options
Every batch is prepared to support accurate and dependable research applications.
CJC + IPA works by combining two complementary mechanisms that influence growth hormone release. CJC-1295 binds to growth hormone releasing hormone receptors and extends signalling activity at the pituitary level, while Ipamorelin selectively stimulates growth hormone secretion through the ghrelin receptor pathway.
This dual action enhances natural pulsatile growth hormone release, supporting more balanced endocrine signalling compared to direct hormone administration.
The resulting increase in GH activity is associated in research with downstream IGF 1 production, which plays a central role in tissue repair, metabolic regulation, and cellular growth processes.
CJC + IPA has been widely studied in experimental settings due to its influence on growth hormone signalling and metabolic pathways.
One of the primary areas of interest is its role in muscle repair, protein synthesis, and recovery from physical stress. Growth hormone signalling is closely linked to lean tissue maintenance and regeneration.
Researchers continue to explore its potential applications in recovery optimisation and tissue repair models.
Growth hormone activity is strongly associated with lipolysis and energy utilisation. CJC + IPA is studied for its potential role in supporting fat metabolism while preserving lean tissue mass.
This makes it relevant in broader research focused on body composition and metabolic regulation.
Growth hormone secretion is closely tied to deep sleep phases. Because of this relationship, CJC + IPA is also studied for its potential influence on sleep quality and overnight recovery processes.
This remains an active area of investigation in endocrine and recovery research.
A major focus of research is the downstream effect of increased GH levels on IGF 1 production. This signalling pathway influences multiple physiological processes including metabolism, tissue repair, and cellular growth.
The GH IGF 1 axis remains one of the most important areas of study in hormone related research.
CJC + IPA is commonly researched in studies involving:
• Growth hormone regulation and endocrine signalling
• Muscle growth and recovery mechanisms
• Fat metabolism and body composition research
• Sleep and regeneration cycles
• Age related hormonal decline studies
Its broad hormonal influence makes it a widely studied combination in metabolic and regenerative science.
Research protocols for CJC + IPA vary depending on study design, model type, and objectives. There is no universally standardised dosing framework, and approaches differ across experimental literature.
The compound is typically supplied in lyophilised form and reconstituted using bacteriostatic water under sterile laboratory conditions. Once prepared, it should be stored refrigerated and handled according to proper laboratory standards.
Researchers are advised to follow established scientific literature when designing experimental protocols.
What is CJC + IPA?
It is a combination of two research peptides, CJC-1295 and Ipamorelin, studied for growth hormone release and metabolic regulation.
How does CJC + IPA work?
It enhances natural growth hormone secretion through dual receptor pathways involving GHRH and ghrelin signalling.
What is CJC + IPA used for in research?
It is studied in muscle recovery, fat metabolism, sleep regulation, and endocrine signalling research.
Is CJC + IPA a hormone replacement?
No, it is researched as a growth hormone stimulating combination rather than a direct hormone replacement.
🚚 Secure tracked shipping available worldwide
⚠️For research purposes only. Not for human or animal consumption.